Breast Cancer
A Phase 3, Randomized, Open-Label Study of Neratinib Versus Lapatinib Plus Capecitabine for the Treatment of ErbB-2?Positive Locally Advanced or Metastatic Breast Cancer
Trial ID: 08200
Contact: Sharon S Ambro
Phone: (972)841-8345
Learn More about this trial.
go back | new search